Equities

Wanbury Ltd

WANBURY:NSI

Wanbury Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)278.79
  • Today's Change12.78 / 4.80%
  • Shares traded169.98k
  • 1 Year change+362.72%
  • Beta1.0588
Data delayed at least 15 minutes, as of Sep 20 2024 11:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income563(103)811
Depreciation/depletion130124114
Non-Cash items30246(551)
Cash taxes paid, supplemental1.831.741.64
Cash interest paid, supplemental347165151
Changes in working capital(684)(69)31
Total cash from operations40198405
INVESTING
Capital expenditures(174)(126)(97)
Other investing and cash flow items, total7.9838102
Total cash from investing(166)(88)5.87
FINANCING
Financing cash flow items603(165)(151)
Total cash dividends paid------
Issuance (retirement) of stock, net600.40497
Issuance (retirement) of debt, net(518)(155)(632)
Total cash from financing146(320)(286)
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash19(210)125
Net cash-begin balance/reserved for future use15225100
Net cash-end balance/reserved for future use3415225
SUPPLEMENTAL INCOME
Depreciation, supplemental130124114
Cash interest paid, supplemental347165151
Cash taxes paid, supplemental1.831.741.64
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.